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Abstract. Hemi-spatial neglect is a disabling, neuropsychological impairment that restricts the ability to attend to incoming
information on one side space. Most frequently associated with a lesion to the right hemisphere, the disorder is strongly predictive
of general functional recovery from stroke. Although the standard therapy is of limited effectiveness, pilot studies indicate that
more effective treatments may follow. Interest in these new potential treatments is, however, beginning to wane as few have
progressed to the stage of randomised, controlled clinical trials. In this brief commentary, we point out that the absence of trials
data not only reflects the preliminary nature of new treatments, but also the practical difficulties associated with meeting the target
enrolment figures of large-scale trials. These problems have likewise slowed the development of treatments for other cognitive
disorders. We suggest ways in which this problem may be overcome.
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1. Introduction
Hemi-spatial neglect (or ‘neglect’ for short) is a
debilitating, attentional disorder that most commonly
arises from damage to the right-side of the brain [1].
Sufferers fail to acknowledge or respond to visual in-
formation presented on the side of space opposite their
brain lesion (e.g. the left), and as such struggle with
many daily routines, often bumping into obstacles, be-
coming lost, and failing to notice people on the affected
side. Prevalence is hard to estimate because diagnostic
criteria differ, but the most conservative estimate in-
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dicates that approximately 62% of those who suffer a
stroke per year will show moderate and severe neglect
in the acute phase, with 23% showing stable impair-
ment beyond three months [2]. To put these numbers
in context, approximately 700,000 U.S. citizens suffer
a stroke each year [3].
Unfortunately, the presence of neglect is very strong-
ly associated with poor general functional outcome. In-
dividuals with neglect (regardless of severity) typically
require additional weeks in hospital, need nearly twice
as many hours of physiotherapy and occupational ther-
apy, and are more prone to falls and persistent urinary
incontinence [4]. Compared to others with the same
Barthel score, patients with neglect at hospital admis-
sion score significantly lower on measures of functional
independence both during hospital stay and 18 months
after leaving [5]. Those who still show neglect on sim-
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ple bedside tests two months after admission have a
higher risk of functional worsening at 1 year follow-
up. Post-discharge, neglect patients are more likely to
require ambulatory assistance and assisted living [4].
Regrettably, neglect is a refractory and difficult con-
dition to treat. According to a recent Cochrane Re-
view [6], “the effectiveness of rehabilitation strategies
for reducing the disabling effects of neglect and in-
creasing independence remain unproven” (p9). On a
brighter note, a number of potentially more effective
treatments, based mostly on sensory stimulation, are
now being developed [7]. However, these have yet to
be properly assessed in large-scale, randomised con-
trolled trials [6]. Based partly on our own attempts to
pilot a vestibular therapy in both the UK and US [8,
9], we wish to point out that the absence of clinical
trials data not only reflects the preliminary nature of
new treatment development, but also the practical dif-
ficulty of recruiting neglect patients into clinical trials.
We expand on this point in the sections below, many
of which speak to the failure to develop effective ther-
apies for other cognitive disorders [10]. However, we
focus on neglect given that it is the most prevalent and
disabling cognitive disorder post-stoke, and also, per-
haps for these reasons, because it has attracted so much
research interest.
The problem of study recruitment stems from the
fact that neglect patients are most commonly found on
acute stroke wards. In some hospitals, staff on these
wards do not routinely screen for neglect so, despite the
poor prognosis of moderate and mild neglect on gen-
eral functional recovery [11], only severe cases tend to
prompt action. The presence of neglect can be further
overlooked if either accompanied, as often the case, by
more observable gross motor impairment, or the pa-
tient is subdued and non-interactive. The likelihood of
study referral is further reduced by the fact that, despite
their best intentions, physicians are often too busy to
devote time to clinical research, and/or may be under
pressure to recruit for multiple clinical trials. Also,
many hospitals seek to discharge acute stroke patients
within 5–6 weeks of admission, which is problemat-
ic because most neglect studies do not recruit until at
least 4 weeks post-onset to allow for any spontaneous
cognitive recovery to occur. This provides a brief time
window in which to assess eligibility, consent, recruit
and test.
Once patients leave an acute care facility, they may
never set foot inside the hospital again and will most
likely not see their attending doctor on follow-up. A
minority of patients with neglect are moved to special-
ist rehabilitation units (typically to receive therapy for
disorders other than neglect), though these often lack
academic affiliation so lack a climate of research and
do not have procedures for ethical review. The majority
of patients go home or to residential care. This creates
logistical difficulties that can be both costly, and time-
consuming, and in instances where the patient is reluc-
tant to travel, presents the problem of creating a con-
trolled test environment at the individual’s residence.
Once patient testing is underway, the current means
of obtaining permission from the relevant institutional
ethics review board to make protocol amendments can
be time-consuming and bureaucratic. This hurdle is
seen by some to reflect a perception within research
and development officers that their role is to control re-
searchers and protect patient well-being, as opposed to
facilitate research and potentially improve well-being.
Unfortunately, these attributes encourage a prescriptive
form of enquiry that is especially obstructive in early-
stage studies where flexibility is needed to finesse and
optimise the evolving protocol.
The problems outlined above highlight a clear dis-
crepancy between the desires of major funding agencies
such as the US National Institutes for Health to trans-
late therapies from bench to bedside, and the realities of
conducting neuropsychological studies that have very
specific inclusion/exclusion criteria and require partic-
ipants that are geographically dispersed. The upshot
is that researchers are more likely to perform under-
powered trials, and worse, are discouraged from future
investigation. Coupled with the intellectual challenge
of finding a treatment regimen that can accommodate
the heterogeneous nature of the hemi-spatial neglect,
it is perhaps unsurprising that the standard, ineffective
treatment of visual scanning has persisted for decades.
What can be done about these problems? We pro-
pose that greater awareness about the disabling effects
of even mild and moderate neglect is needed amongst
physicians and therapists of acute stroke. Second, new
treatments must be cheaper and easier to implement at
home to fit around the increasing pressure to reduce
length of hospital stay. Third, the development of non-
pharmacological interventions for cognitive disorders
such as neglect requires participant numbers that cannot
be delivered within most single institutions. Yet there is
no established mechanism for multi-centre, city-wide
or regional pooling of potential participants. We pro-
pose that research funding agencies provide infrastruc-
ture grants that would support the identification of par-
ticipants with similar diagnoses who would be willing
to participate in trials once they were medically stable.
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The idea would be to compile a national registry of par-
ticipants who had given local consent to be contacted
about research participation. This anonymous database
would provide basic demographic and diagnostic in-
formation, and would be publicly available. In princi-
ple, it need not be restricted to the clinical syndrome of
neglect, and could carry information about other dis-
orders. However, only those who had submitted suc-
cessful grant applications would be able to apply for
access to patients. Of course, such an initiative would
need to meet the challenge of managing requests for the
same patients from different research groups. But we
consider this a small price to pay if the queue of new,
promising therapies that await trials validation can be
relieved.
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